-----BEGIN PRIVACY-ENHANCED MESSAGE----- Proc-Type: 2001,MIC-CLEAR Originator-Name: webmaster@www.sec.gov Originator-Key-Asymmetric: MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB MIC-Info: RSA-MD5,RSA, N150SM+JoI5X/MsUS9ei/V5UKFQNKwS0dCzP43sQnLkwT7c53MbkqmFaZVo7N/9s LkdErHjE31BBrz+CHmzPxg== 0001193125-07-030636.txt : 20070214 0001193125-07-030636.hdr.sgml : 20070214 20070214090158 ACCESSION NUMBER: 0001193125-07-030636 CONFORMED SUBMISSION TYPE: SC 13G/A PUBLIC DOCUMENT COUNT: 1 FILED AS OF DATE: 20070214 DATE AS OF CHANGE: 20070214 FILED BY: COMPANY DATA: COMPANY CONFORMED NAME: Lipschutz Lester E CENTRAL INDEX KEY: 0001308379 FILING VALUES: FORM TYPE: SC 13G/A BUSINESS ADDRESS: BUSINESS PHONE: 215 977 2046 MAIL ADDRESS: STREET 1: WOLF BLOCK SCHORR AND SOLIS COHEN STREET 2: 1650 ARCH STREET CITY: PHILADELPHIA STATE: PA ZIP: 19103 FORMER COMPANY: FORMER CONFORMED NAME: Lipshutz Lester E DATE OF NAME CHANGE: 20041110 SUBJECT COMPANY: COMPANY DATA: COMPANY CONFORMED NAME: Hana Biosciences Inc CENTRAL INDEX KEY: 0001140028 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 841588441 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: SC 13G/A SEC ACT: 1934 Act SEC FILE NUMBER: 005-79910 FILM NUMBER: 07613891 BUSINESS ADDRESS: STREET 1: 7000 SHORELINE COURT STREET 2: SUITE 370 CITY: SOUTH SAN FRANCISCO STATE: CA ZIP: 94080 BUSINESS PHONE: 6505886404 MAIL ADDRESS: STREET 1: 7000 SHORELINE COURT STREET 2: SUITE 370 CITY: SOUTH SAN FRANCISCO STATE: CA ZIP: 94080 FORMER COMPANY: FORMER CONFORMED NAME: EMAIL REAL ESTATE COM INC DATE OF NAME CHANGE: 20010504 SC 13G/A 1 dsc13ga.htm AMENDMENT NO. 1 TO SCHEDULE 13G Amendment No. 1 to Schedule 13G

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

WASHINGTON, D.C. 20549

 

SCHEDULE 13G/A

(Amendment No. 1)

 

Under the Securities Exchange Act of 1934

 

 

 

 

Hana Biosciences, Inc.

(Name of Issuer)

 

 

Common Stock, par value $.001 per share

(Title of Class of Securities)

 

 

268749108

(CUSIP NUMBER)

 

 

December 31, 2006

(Date of Event Which Requires Filing of this Statement)

 

Check the appropriate box to designate the rule pursuant to which this Schedule is filed:

¨ Rule 13d-1(b)

x Rule 13d-1(c)

¨ Rule 13d-1(d)

SCHEDULE 13G

CUSIP No. 268749108

 

  1.  

NAME OF REPORTING PERSONS: LESTER E. LIPSHUTZ

I.R.S. IDENTIFICATION NOS. OF ABOVE PERSONS (ENTITIES ONLY).

 

    
  2.  

CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP

(a)  ¨

(b)  ¨

    
  3.  

SEC USE ONLY

 

    
  4.  

CITIZENSHIP OR PLACE OF ORGANIZATION

 

UNITED STATES

    

 

NUMBER OF  

SHARES  

BENEFICIALLY  

OWNED BY  

EACH  

REPORTING  

PERSON  

WITH  

 

  

  5.    SOLE VOTING POWER

 

        1,329,079

 

  6.    SHARED VOTING POWER

 

        0

 

  7.    SOLE DISPOSITIVE POWER

 

        1,329,079

 

  8.    SHARED DISPOSITIVE POWER

 

        0

  9.  

AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON

 

1,329,079

    
10.  

CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES

 

 

¨

    
11.  

PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (9)

 

4.54(1)

    
12.  

TYPE OF REPORTING PERSON

 

IN

    

 

SCHEDULE 13G

CUSIP No. 268749108

 

Item 1(a). Name of Issuer:

Hana Biosciences, Inc.

 

Item 1(b). Address of Issuer’s Principal Executive Offices:

400 Oyster Point Blvd.

Suite 215

South San Francisco, CA 94080

 

Item 2(a). Name of Person Filing:

Lester E. Lipshutz

 

Item 2(b). Address of Principal Business Office or, if None, Residence:

Wolf, Block, Schorr and Solis-Cohen, LLP

1650 Arch Street- 22nd Floor

Philadelphia, PA 19103

 

Item 2(c). Citizenship:

United States

 

Item 2(d). Title of Class of Securities:

Common Stock

 

Item 2(e). CUSIP Number:

268749108

 

Item 3. If this statement is filed pursuant to Rule 13d-1(b), or 13d-2(b) or (c), check whether the person filing is a: Not Applicable

 

  (a)    ¨ Broker or dealer registered under Section 15 of the Exchange Act;

 

  (b)    ¨ Bank as defined in Section 3(a)(6) of the Exchange Act;

 

  (c)    ¨ Insurance Company as defined in Section 3(a)(19) of the Exchange Act;

 

  (d)    ¨ Investment Company registered under Section 8 of the Investment Company Exchange Act;

 

-3-

SCHEDULE 13G

CUSIP No. 268749108

 

  (e)    ¨ Investment Adviser in accordance with Rule 13d-1(b)(1)(ii)(E);

 

  (f)     ¨ Employee Benefit Plan or Endowment Fund in accordance with Rule 13d-1(b)(1)(ii)(F);

 

  (g)    ¨ Parent Holding Company or Control Person in accordance with Rule 13d-1(b)(1)(ii)(G);

 

  (h)    ¨ Saving Association as defined in Section 3(b) of The Federal Deposit Insurance Act;

 

  (i)     ¨ Church Plan that is excluded from the definition of an Investment Company under Section 3(c)(14) of the Investment Company Act;

 

  (j)     ¨ Group, in accordance with Rule 13d-1(b)(1)(ii)(J).

 

Item 4. Ownership.

(a) Amount beneficially owned: Mr. Lipshutz may be deemed the beneficial owner of 1,329,079 shares. Beneficial ownership consists of voting and dispositive power over (i) 172,083 shares owned by the Lindsay A. Rosenwald Alaska Irrevocable Indenture of Trust for which Mr. Lipshutz is trustee; (ii) 172,083 shares owned by the Lindsay A. Rosenwald Rhode Island Irrevocable Indenture of Trust for which Mr, Lipshutz serves as the adviser; (iii) 172,083 shares owned by the Lindsay A. Rosenwald Nevada Irrevocable Indenture of Trust for which Mr. Lipshutz is trustee; and (iv) 812,830 shares owned by the Rosenwald 2000 Family Trusts for which Mr. Lipshutz is the trustee. Mr. Lipshutz disclaims beneficial ownership of these securities and the filing of this report is not an admission that Mr. Lipshutz is the beneficial owner of these securities.

(b) Percent of Class: 4.54%(1)

(c) Number of shares as to which such person has:

(i) Sole power to vote or direct the vote: 1,329,079

(ii) Shared power to vote or to direct the vote: 0

(iii) Sole power to dispose or direct the disposition of: 1,329,079

(iv) Shared power to dispose or to direct the disposition of: 0

 

Item 5. Ownership of Five Percent or Less of a Class.

If this statement is being filed to report the fact that as of the date hereof the reporting person has ceased to be the beneficial owner of more than five percent of the class of securities, check the following: x

 

-4-

SCHEDULE 13G

CUSIP No. 268749108

 

Item 6. Ownership of More than Five Percent on Behalf of Another Person.

As of December 31, 2006, Mr. Lipshutz serves as (i) trustee of the Lindsay A. Rosenwald Alaska Irrevocable Indenture of Trust; (ii) adviser of the Lindsay A. Rosenwald Rhode Island Irrevocable Indenture of Trust; (iii) trustee of the Lindsay A. Rosenwald Nevada Irrevocable Indenture of Trust; and (iv) trustee of the Rosenwald 2000 Family Trusts. Mr. Lipshutz has the power to direct receipt of the proceeds from a sale of the shares owned by each such trust.

 

Item 7. Identification and Classification of the Subsidiary Which Acquired the Security Being Reported on by the Parent Holding Company.

Not Applicable

 

Item 8. Identification and Classification of Members of the Group.

Not Applicable

 

Item 9. Notice of Dissolution of Group.

Not Applicable

 

Item 10. Certification.

By signing below I certify that, to the best of my knowledge and belief, the securities referred to above were not acquired and are not held for the purpose of or with the effect of changing or influencing the control of the issuer of the securities and were not acquired and are not held in connection with or as a participant in any transaction having that purpose or effect.

SIGNATURE

After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct.

 

February 14, 2007
(Date)
Lester E. Lipshutz
(Signature)
Lester E. Lipshutz
(Name/Title)

 

-5-

SCHEDULE 13G

CUSIP No. 268749108

(1) Based on 29,287,039 shares reported outstanding at January 26, 2007.

 

-6-

-----END PRIVACY-ENHANCED MESSAGE-----